Side Effects of Rozerem

Drowsiness, dizziness, and fatigue are some of the more common side effects of Rozerem. Most side effects are considered minor and do not require medical attention. However, you should notify your healthcare provider immediately if you experience serious Rozerem side effects, such as depression, hallucinations, or suicidal thoughts.

Side Effects of Rozerem: An Introduction

As with any medicine, there are possible side effects with Rozerem® (ramelteon). However, not everyone who takes the drug will experience side effects. In fact, most people tolerate the sleep medicine well. If side effects do occur, they are generally minor and either require no treatment or can easily be treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with Rozerem. Your healthcare provider can discuss a more complete list of Rozerem side effects with you.)
 

Common Rozerem Side Effects

Rozerem has been studied extensively in clinical trials, with many people having been evaluated. In these studies, side effects occurring in the group of people taking the drug are always documented and compared to the side effects that occur in a similar group of people not taking the medicine. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
 
Based on these studies, the most common side effects of Rozerem include:
 
  • Drowsiness -- in up to 5 percent of people
  • Dizziness -- up to 5 percent
  • Fatigue -- up to 4 percent
  • Nausea -- up to 3 percent
  • Worsened insomnia -- up to 3 percent
  • Upper respiratory tract infections (such as the common cold) -- up to 3 percent
  • Muscle pain -- up to 2 percent
  • Depression -- up to 2 percent (see Rozerem and Depression)
  • Taste changes -- up to 2 percent
  • Influenza (the flu) -- up to 1 percent.
     
(Side Effects of Rozerem Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation